| SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses A Christofides, XL Katopodi, C Cao, D Karagkouni, K Aliazis, ... Nature Immunology 24 (1), 55-68, 2023 | 52 | 2023 |
| The human liver microenvironment shapes the homing and function of CD4+ T-cell populations BG Wiggins, LJ Pallett, X Li, SP Davies, OE Amin, US Gill, S Kucykowicz, ... Gut 71 (7), 1399-1411, 2022 | 40 | 2022 |
| Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases B Ibis, K Aliazis, C Cao, S Yenyuwadee, VA Boussiotis Frontiers in Immunology 14, 1197364, 2023 | 37 | 2023 |
| Immune cellular components and signaling pathways in the tumor microenvironment S Yenyuwadee, K Aliazis, Q Wang, A Christofides, R Shah, N Patsoukis, ... Seminars in cancer biology 86, 187-201, 2022 | 33 | 2022 |
| Driver mutations dictate the immunologic landscape and response to checkpoint immunotherapy of glioblastoma AT Yeo, R Shah, K Aliazis, R Pal, T Xu, P Zhang, S Rawal, CM Rose, ... Cancer immunology research 11 (5), 629-645, 2023 | 11 | 2023 |
| The putative roles and functions of indel, repetition and duplication events in alphavirus non-structural protein 3 hypervariable domain (nsP3 HVD) in evolution, viability and … N Abdullah, N Ahemad, K Aliazis, JE Khairat, TC Lee, SA Abdul Ahmad, ... Viruses 13 (6), 1021, 2021 | 6 | 2021 |
| In Vitro and Ex Vivo Models to Study T Cell Migration Through the Human Liver Parenchyma BG Wiggins, K Aliazis, SP Davies, G Hirschfield, PF Lalor, G Reynolds, ... T-Cell Trafficking: Methods and Protocols, 195-214, 2017 | 5 | 2017 |
| The effect of pharmacological cessation and restoration of menstrual cycle on bone metabolism in premenopausal women with endometriosis AD Anastasilakis, S Papachatzopoulos, P Makras, A Gkiomisi, ... Bone 158, 116354, 2022 | 3 | 2022 |
| Emergency myelopoiesis in solid cancers K Aliazis, S Yenyuwadee, P Phikulsod, VA Boussiotis British journal of haematology 205 (3), 798-811, 2024 | 2 | 2024 |
| Loss of LDH-a Accelerated CD8+ T Memory Cell Differentiation but Impairs Anti-Tumor Responses R Shah, K Aliazis, LX Katopodi, AA Christofides, HI Aksoylar, ... Blood 144, 123, 2024 | | 2024 |
| PD-L1 deletion on T cells results in a pro-tumorigenic environment K Aliazis, R Shah, S Yenyuwadee, R Pal, V Boussiotis The Journal of Immunology 212 (1_Supplement), 1240_5464-1240_5464, 2024 | | 2024 |
| A four-cell pathway orchestrated by Flt3-L-dependent cDCs controls anti-tumor responses K Aliazis, VA Boussiotis Cell Reports Medicine 5 (1), 2024 | | 2024 |
| PD-1 Expression By Dendritic Cells Is a Key Regulator of T-Cell Immunity in Cancer R Shah, K Aliazis, A Christofides, AA Pham, R Pal, VA Boussiotis Blood 142 (Supplement 1), 2538-2538, 2023 | | 2023 |
| Pparβ/δ Has an Indispensable Role in T Cell Function and Anti-Tumor Responses B Ibis, A Christofides, K Aliazis, R Shah, R Pal, VA Boussiotis Blood 142, 1180, 2023 | | 2023 |
| Specific PD-1 Deletion on Regulatory T Cells Leads to Enhanced Anti-Tumor Responses K Aliazis, A Christofides, HI Aksoylar, R Shah, R Pal, N Patsoukis, ... Blood 142, 2551, 2023 | | 2023 |
| 42243 RIAM regulates T cell migration and activation in melanoma S Yenyuwadee, K Aliazis, A Christofides, HI Aksoylar, R Pal, ... Journal of the American Academy of Dermatology 89 (3), AB82, 2023 | | 2023 |
| Betul Ibis1, 2, Konstantinos Aliazis1, 2, Carol Cao1, 2, 3, Sasitorn Yenyuwadee1, 2 and Vassiliki A. Boussiotis1, 2, 4 S Yenyuwadee, B Ibis, K Aliazis, C Cao, S Yenyuwadee | | 2023 |
| SHP-2 Regulates Myeloid Cell Differentiation, Anti-Tumor Responses and Innate Immune Memory A Christofides, XL Katopodi, C Cao, D Karagkouni, K Aliazis, ... Blood 140 (Supplement 1), 1403-1404, 2022 | | 2022 |
| The role of the CD28-CD80 axis and molecular inhibitors of T cell co-stimulation in the potential treatment of autoimmune cholestatic liver diseases K Aliazis University of Birmingham, 2022 | | 2022 |
| BMD AND BONE TURNOVER MARKERS ALTERATIONS IN WOMEN WITH ENDOMETRIOSIS DURING MENSTRUAL CESSATION DUE TO GNRH THERAPY AND AFTER MENSTRUAL RESTORATION AD Anastasilakis, S Papachatzopoulos, MP Yavropoulou, A Gkiomisi, ... OSTEOPOROSIS INTERNATIONAL 32 (SUPPL 1), S227-S227, 2021 | | 2021 |
Vassiliki BoussiotisProfessor of Medicine, Harvard UniversityVerified email at bidmc.harvard.edu
